A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine

J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e747-e749. doi: 10.1111/jdv.18269. Epub 2022 Jun 7.

Authors

F Filippi^{1

2}, C Baraldi^{1

2}, P L Zinzani³, B Casadei³, A Pileri^{1

2}

Affiliations

¹ Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum University of Bologna, Bologna, Italy.
² Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
³ IRCCS Azienda Ospedaliero, Istituto di Ematologia 'Seràgnoli', Università di Bologna, Bologna, Italy.

No abstract available

Keywords: COVID-19; drug rash; vaccine; viral disease.

Publication types

Case Reports
Letter

MeSH terms

Aged
COVID-19 Vaccines* / adverse effects
COVID-19* / prevention & control
Humans
Male
Pityriasis Lichenoides*

Substances

COVID-19 Vaccines